1. Paget’s disease of the nipple

   • Ana C. Sandoval-Leon
   • Katherine Drews-Elger
   • Marc E. Lippman

   Review 09 August 2013 Pages: 1 - 12

   

2. The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis

   • Josh J. Carlson
   • Joshua A. Roth

   Review 24 August 2013 Pages: 13 - 22

   

3. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis

   • Yan-Mei Wu
   • Wei Hu
   • Wei-Qiang Zheng

   Preclinical Study 10 August 2013 Pages: 23 - 32

   

4. Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model

   • Bauke Anninga
   • Muneer Ahmed
   • Michael Douek

   Preclinical study 17 August 2013 Pages: 33 - 42

   

5. HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

   • Allan Lipton
   • Laurie Goodman
   • Michael Bates

   Preclinical Study Open access 20 August 2013 Pages: 43 - 53

   

6. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells

   • Angela Catania
   • Enrique Barrajón-Catalán
   • Vicente Micol

   Preclinical study 20 August 2013 Pages: 55 - 65

   

7. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling

   • Claudia Fumarola
   • Cristina Caffarra
   • Mara A. Bonelli

   Preclinical Study 21 August 2013 Pages: 67 - 78

   

8. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment

   • Tuomas Heikkinen
   • Taina Korpela
   • Heli Nevanlinna

   Preclinical Study 24 August 2013 Pages: 79 - 88

   

9. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients

   • Sung Gwe Ahn
   • Seung Myung Dong
   • Jeffrey E. Green

   Clinical Trial 10 August 2013 Pages: 89 - 99

   

10. Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

    • M. Campiglio
    • R. Bufalino
    • E. Tagliabue

    Clinical Trial Open access 13 August 2013 Pages: 101 - 110

    

11. The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study

    • Dominique Frechette
    • Lise Paquet
    • Susan Dent

    Clinical trial 14 August 2013 Pages: 111 - 117

12. Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

    • Luigi Di Lauro
    • Patrizia Vici
    • Marcello Maugeri-Saccà

    Clinical trial 28 August 2013 Pages: 119 - 123

    

13. High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy

    • Penny Fang
    • Kay See Tan
    • Lilie L. Lin

    Epidemiology 14 August 2013 Pages: 125 - 133

    

14. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests

    • P. Pujol
    • D. Stoppa Lyonnet
    • C. Nogues

    Epidemiology 24 August 2013 Pages: 135 - 144

    

15. Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study

    • Brian L. Sprague
    • Vicki McLaughlin
    • Amy Trentham-Dietz

    Epidemiology 25 August 2013 Pages: 145 - 154

    

16. Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer

    • Brigid K. Killelea
    • Jessica B. Long
    • Cary P. Gross

    Brief Report 14 August 2013 Pages: 155 - 163

    

17. Erratum to: DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study

    • Meng Hua Tao
    • Peter G. Shields
    • Jo L. Freudenheim

    Erratum 11 August 2013 Pages: 165 - 165